These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22174163)

  • 21. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
    Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
    J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
    Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
    Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
    Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relevance of tumor angiogenesis in occurrence and development of breast cancer].
    Liu Y; Wang G; Xu WG; Song JN; Yang XQ; Wang WY
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1687-9. PubMed ID: 19957527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
    Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis.
    Gisterek I; Matkowski R; Koźlak J; Duś D; Lacko A; Szelachowska J; Kornafel J
    Anticancer Res; 2007; 27(4C):2797-802. PubMed ID: 17695450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral FOXP3 expression in infiltrating breast carcinoma: Its association with clinicopathologic parameters and angiogenesis.
    Gupta S; Joshi K; Wig JD; Arora SK
    Acta Oncol; 2007; 46(6):792-7. PubMed ID: 17653902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of angiogenesis in the tumorigenesis and progression of breast cancer].
    Li YJ; Deng YJ; Wen G; Zhang XL
    Zhonghua Wai Ke Za Zhi; 2009 Apr; 47(7):519-22. PubMed ID: 19595210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
    Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
    Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of vascular endothelial growth factor and its receptor Flk-1/KDR in benign and malignant breast neoplasms].
    Li YJ; Wen G; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):70-1, 74. PubMed ID: 19218116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yoshidome K; Nakahara M; Nakao K; Nakamura M; Kakudo K
    Clin Cancer Res; 2006 Feb; 12(4):1201-7. PubMed ID: 16489074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.